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Downregulation of VANGL1 Inhibits Cellular Invasion
Rather than Cell Motility in Hepatocellular
Carcinoma Cells Without Stimulation
Gokhan Ozan Cetin,* Asli Toylu,{ Nese Atabey, Zeynep Sercan, and Meral Sakizli
Aims: The Wnt planar cell polarity (PCP) pathway is one of the Wnt pathways which plays a critical role in cell
proliferation and fate. The VANGL1 protein is one of Wnt-PCP pathway components. It is known that Wnt-
PCP pathway has major roles in cell motility but its role in hepatocellular carcinoma (HCC) progression
through invasion and metastasis needs to be clarified. Methods: We silenced VANGL1 gene expression in the
HepG2 HCC cell line by stable transfection with a vector containing siRNA template for VANGL1 and
investigated the change in cell invasion and motility. Results: Transfected cells with the siRNA template
showed significantly suppressed invasive capacity when compared to controls although cellular motility was
only slightly affected. Conclusion: Our study showed a basal role for VANGL1 with respect to the invasive
capacity of HCC cells. This suggests that the Wnt-PCP pathway may play a role in progression of HCC through
cellular invasion but further studies are needed to clarify its role in cell motility.
Introduction
Hepatocellular carcinoma (HCC) is the fifth mostfrequent cancer worldwide and is responsible for an
estimated 600,000 deaths annually (Llovet et al., 2003).
There is no effective treatment for this malignancy and a
number of molecular changes, including hypermethylation or
hypomethylation changes, mutations, and loss of heterozy-
gosity of some genes, were thought to be associated with its
development; however, there is no specific mechanism im-
plicated in HCC (Moeini et al., 2012).
The Wnt proteins are a large family of highly conserved
glycoproteins that have multiple roles in the cell fate and
development of several organisms. Wnt pathways regulate
different cellular functions, such as proliferation, differenti-
ation, polarity, survival, and migration, and affect the orga-
nization of body plan, organogenesis, and tissue patterning
during development (Go´mez-Orte et al., 2013; Rosenbluh
et al., 2014). The activation of Wnt signaling contributes to
the etiology of several human cancers and may participate
in malignant metastasis (An et al., 2013; Gao et al., 2014).
While the Wnt/b-catenin pathway (known as canonical)
plays a major role in Wnt signaling, there are also alternative
(noncanonical) pathways, including the Wnt-planar cell po-
larity (PCP) and Wnt-Ca + 2 pathways (Takahashi-Yanaga
and Kahn, 2010). The Wnt system regulates motility and
invasion not only by the canonical pathway but also by the
PCP pathway in neoplasia as well as in physiologic pro-
cesses. Although alterations in the Wnt/b-catenin pathway
have been reported to be involved in hepatocarcinogenesis,
there are limited data related to the Wnt/PCP pathway in
HCC (Ikenoue et al., 2002; Pez et al., 2013).
It is well known that the components of the noncanonical
Wnt pathway are essential for the regulation of PCP during
embryonic differentiation. The core components of this
pathway are Frizzled (Fz), Van Gogh (Vang), (Strabismus
[Stbm]), Flamingo (Fmi), Disheveled (Dsh), Prickle (Pk),
and Diego proteins. The PCP is established by both the Fz
gradient and the asymmetric distribution of core PCP proteins
in the surface of cells (Rosso and Inestrosa, 2013). Con-
vergent extension movement of embryonic cells is also me-
diated by the noncanonical Wnt pathway (Walck-Shannon
et al., 2014). Although various other signaling pathways
besides the Wnt pathway have been implicated in cell mo-
tility, several data indicate that the noncanonical Wnt sig-
naling pathway has the major role in migration during
embryogenesis (Walck-Shannon and Hardin, 2014).
The VANGL1 gene is located on human chromosome
1p13. It encodes a transmembrane protein that interacts with
PCP core proteins Disheveled (Dvl), Prickle (Pk), and Friz-
zled (Fz), a tumor metastasis suppressor KAI1 protein, and
an intestinal epithelial restitution factor ITF protein ( Jenny
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et al., 2003). The role of VANGL1 in normal and malignant
human cells needs to be further investigated to better un-
derstand the mechanisms of cell invasion and motility. In
this study, we investigated the effects of the inhibition of
VANGL1 gene expression on cellular motility and invasion
on human HCC cells by the siRNA method.
Materials and Methods
Cell lines and cell culture
Human HCC cell lines HEP-G2, HEP-3B, and SK-HEP-1,
the colon adenocarcinoma cell line SW-480, and the chronic
myeloid leukemia cell line K-562 were grown in Dulbecco’s
Modified Eagle’s Medium (DMEM; Sigma-Aldrich) sup-
plemented with 10% fetal bovine serum (FBS; Sigma-
Aldrich), 2mM L-glutamine (Sigma-Aldrich), and 100 IU/mL
penicillin (Sigma-Aldrich), and 100 mg/mL streptomycin
(Sigma-Aldrich) and cultured at 37C humid air containing
5% CO2.
Real-time reverse transcriptase-polymerase
chain reaction
Total RNA was extracted from the cell lines with the Nu-
cleospin RNA II kit (Macherey Nagel), and first-strand
cDNA synthesis was performed with the RevertAid First
Strand cDNA synthesis Kit (Fermentas) according to the
manufacturer’s protocols. Real-time reverse transcriptase-
polymerase chain reaction (RT-PCR) was performed in
LightCycler 2.0 (Roche) using the FastStart DNA Master
SYBR Green I Kit (Roche). The PCR conditions were 95C
for 10min followed by 28 cycles of 95C for 10 s, 59C for
10 s, and 72C for 20 s. In real-time PCR, theHPRT1 genewas
used as a housekeeping gene and relative quantification of the
products was carried out using the LightCycler Software 4.0.
Primer sequences were as follows: for VANGL1 (179bp prod-
uct), forward 5¢-ATCACCAACGGCATGACC-3¢ and reverse
5¢-AGGCTGAAGTCCAAGCAC-3¢ and forHPRT1 (262bp
product), forward 5¢-GTGGAGATGATCTCTCAACT-3¢ and
reverse 5¢-ACATGATTCAAATCCCTGAAG-3¢.
Construction of shRNA expression plasmid
and transfection
The shRNA template for VANGL1 gene silencing was
designed using a web-based tool (https://rnaidesigner.life-
technologies.com/rnaiexpress/). The sequence of the shRNA
template for VANGL1 gene was sense strand 5¢-GATC
CGCCACAACGAGTTGTATTA TTCAAGAGATAATAC
AACTCGTTGTGGCTTA-3¢ and antisense strand 5¢-AG
CTT AAGCCACAACGAGTTGTATTATCTCTTGAATA
ATACAACTCGTTGTGGCG-3¢. The oligonucleotides were
annealed and inserted into pSilencer 4.1-CMV-Neo plas-
mid (Ambion) and maxipreparation of the plasmid was per-
formed; then, the plasmid was controlled by the sequence
analysis. To create stable clones of HEP-G2 cells carrying
pSilencer 4.1-CMV Neo plasmid, HEP-G2 cells were trans-
fected with the plasmid using Tfx 50 reagent (Promega).
Selection of transfected HEP-G2 cells was performed with
culturing the cells in complete DMEM supplemented with
1000 mg/mL Geneticin as a selection agent. HEP-G2 cells
were incubated for 3 weeks and the cell culture medium was
replaced every 48 h. At the end of the incubation period,
colonies of the stably transfected cells were picked up by
cloning disks (Sigma-Aldrich).
Western blot analysis
Proteins were subjected to SDS-PAGE under reducing
conditions and then electrophoretically transferred to the
nitrocellulose membrane. After blocking with 5% nonfat
dried milk in the TBS-Tween 20 buffer at room temperature
for 30min, nitrocellulose membranes were sequentially
blotted at 4C for overnight with the anti-VANGL1 antibody
(Sigma-Aldrich) and for 45min at room temperature with
horseradish peroxidase-conjugated anti-rabbit IG (Amer-
sham). Protein bands were visualized with enhanced chemi-
luminescence.
Motility and invasion assays
Motility and invasion assays were performed in modified
Boyden chambers with 8.0 mm pore size (BD Clontech).
Motility chambers coated with the Matrigel matrix (BD
Clontech) were used as invasion chambers. Cells were seeded
into the upper reservoir of motility or invasion chambers and
were cultured in the complete DMEM supplemented with 2%
FBS for 48 h. The cells that migrated through the pores of the
chambers were stained and then counted with an inverted
microscope.
Statistical analyses
The GraphPad Prism 2.0 software (GraphPad Software,
Inc.) was used for statistical analyses. The Mann–Whitney U
test was performed to analyze the significance of the differ-
ences between the cells.
Results
Relative quantification of VANGL1 gene expression in
HEP-G2, HEP-3B, and SK-HEP-1 cell lines was determined
by quantitative RT-PCR, while SW-480 and K-562 cell lines
were used as controls. HEP-G2 cells were found to express
VANGL1more than HEP-3B and SK-HEP-1 cells (Fig. 1) and
subsequent experiments were carried out with the HEP-G2
cell line.
FIG. 1. Relative quantification of VANGL1 expression
with real-time polymerase chain reaction (PCR) in hepato-
cellular cancer cell lines.
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To silence the VANGL1 gene, HEP-G2 cells were trans-
fected with the pSilencer 4.1 vector containing the template
for shRNA expression. To detect the degree of gene ex-
pression at the mRNA level after shRNA transfection, rela-
tive quantification was performed by real-time PCR (Fig. 2a).
Nearly 70% VANGL1 gene silencing at the mRNA level was
achieved and western blot analysis confirmed the gene si-
lencing at the protein level (Fig. 2b).
Motility and invasion assays to assess the invasion ca-
pacity of the cells after VANGL1 silencing were carried out
with HEP-G2 cells with the silenced VANGL1 gene (pSIL-
VANGL1) and a control colony transfected with the control
plasmid (pSIL). When compared to the control cells, the cells
with the silenced VANGL1 gene showed a more suppressed
invasive capacity (Fig. 3a). Motility assay results showed that
there is minimal difference between the control cells and the
VANGL1 gene-silenced HEP-G2 cells (Fig. 3b).
Discussion
The effects of VANGL1 gene silencing on the cellular in-
vasion and motility were investigated in this study. The
shRNA application method of stable gene silencing was
performed to inhibit the expression of the VANGL1 gene in
the HEP-G2 hepatocellular carcinoma cell line. Invasion
assays revealed a significantly reduced invasive capacity of
the cells with the silenced VANGL1 gene, whereas motility
assays showed a slight but insignificant difference compared
to control cells. These results implicated that the VANGL1
protein was mostly involved in cell invasion rather than cell
motility.
Transient siRNA silencing of the VANGL1 gene in various
cancer cell lines was reported to regulate cellular invasion
and motility. In gastric carcinoma, colorectal cancer, and oral
cancer cell lines, fibronectin-stimulated cellular invasion of
gelatin was shown to be decreased, and motility of the cells
was found to be reduced with the scratch wound assay fol-
lowing transient siRNA silencing of the VANGL1 gene (Ryu
et al., 2010; Lee et al., 2011; Yoon et al., 2013). Although our
invasion assay results were similar, our motility assay results
were not similar to these reports and there were differences in
the assay methods used to analyze cellular motility and in-
vasion. In our assays, invasion was measured with Matrigel
matrix-coated transwell chambers and there was no stimu-
lating agent to induce cell invasion. While the Matrigel ma-
trix invasion assay has a superior capacity to analyze cellular
invasion since it contains numerous molecules, including
laminin, collagen IV, enactin, and fibronectin, only the gel-
atin matrix has collagen molecules (Kleinman and Martin,
2005). Associated with the multimolecular composition of
FIG. 2. (a) VANGL1 expression of HEP-
G2 cells transfected with pSilencer plasmid.
pSIL-VANGL1 cells carry the shRNA tem-
plate for VANGL1 and pSIL where the
control cells transfected with the control
pSilencer vector. Relative quantification of
VANGL1 expression with real-time PCR in
transfected cells showing the degree of gene
silencing ( p = 0.0009). *Indicates the sig-
nificance. (b) Western blot analysis of
VANGL1 expression in the cells transfected
with siRNA.
FIG. 3. The change in the number of (a)
invasive ( p = 0.03) and (b) motile HEP-G2
cells after transfection with VANGL1
siRNA. *Indicates the significance. pSIL-
VANGL1 cells carry the shRNA template
for VANGL1 and pSIL where the control
cells transfected with the control pSilencer
vector.
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the Matrigel matrix, cellular response to invade the Matrigel
matrix is more complex than the gelatin matrix (Brinckerhoff
et al., 2000). Therefore, we preferred to use the Matrigel
matrix assay method to analyze basal invasion capacity of
cells without stimulation.
In the previous studies, motility assays were performed
with the scratch wound assay, but in our experiments,
transwell chambers were used to investigate cell motility
(Ryu et al., 2010; Lee et al., 2011; Yoon et al., 2013). Since
the cytoskeletal movement of the cell has a similar pattern in
both transwell migration and invasion experiments, we pre-
ferred to use the transwell migration assay instead of the
wound closure assay (Albini et al., 1987; Mierke, 2013). In
one study, the effect of VANGL1 silencing on cellular mi-
gration was analyzed with the transwell assay as in our ex-
periments, and their results showed that motility of the breast
cancer cells reduced with VANGL1 silencing (Anastas et al.,
2012). Our findings are not concordant with this report, and
we suppose that VANGL1 silencing may be resulting with a
different effect on cellular motility depending on the cell
type. In addition, the influence of the VANGL1 protein on
cellular motility might be more pronounced under specific
conditions, which are stimulating the cellular motility re-
sponse. It has been shown that VANGL1 silencing reduced
the ITF-stimulated migration of intestinal epithelial cells, but
did not affect the basal motility of these cells (Kalabis et al.,
2006). Moreover, the discrepancy of our motility assay re-
sults with the previous studies may be related with the siRNA
silencing method whether transient or stable.
The mechanism of the inhibition of cell invasion with
transient VANGL1 silencing was reported to be associated
with the regulation of the extracellular matrix. Results
showed that the silencing of the VANGL1 gene inhibits the
transcription of metalloproteinase enzymes, which are de-
grading the extracellular matrix proteins with their proteo-
lytic enzyme activity. The association of Vangl1 protein with
cell invasion and motility might also be related by its effect
on the cell adhesion. A number of molecules, which are lo-
cated downstream of the VANGL1 on theWnt-PCP pathway,
have a role in the regulation of both cell to cell and cell to
extracellular matrix adhesion. Particularly, the activity of
small GTPases, like Rac and RhoA proteins, contributes to
the inactivation of cadherin-mediated cell to cell adhesion in
human cancer (Evers et al., 2000; Fort and The´veneau, 2014).
Moreover, Rac and RhoA proteins are involved in cell mo-
tility and the invasion processes with their role in the for-
mation of lamellipodia, membrane ruffles, focal contacts, and
cytoskeletal changes (Hall, 1998). Both the loss of intercel-
lular adhesion and the stimulation of migration are well-
known characteristic features of invasive cancers. Recently,
studies with breast cancer and HCC tissues showed that
cancer cells have a higher expression level of the VANGL1
gene compared to normal cells (Cho et al., 2011; Anastas
et al., 2012). Furthermore, both in colon adenocarcinomas
and gastric tumors, metastatic cancer tissues were found to
have an elevated VANGL1 protein expression (Kho et al.,
2009; Ryu et al., 2010). These data are implying that the
increased levels of the VANGL1 protein might be associated
with the invasion and metastatic progression of cancer cells.
Taken together, we propose that VANGL1 is associated to
the natural invasion capacity of HCC cells rather than mo-
tility, and further studies need to be performed to understand
both basal and stimulated cellular invasion related with the
VANGL1 protein in distinct types of cancer.
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